
### [MONDO:0004980](http://purl.obolibrary.org/obo/MONDO_0004980)
**Label:** atopic eczema

**Subclasses:** [MONDO:0011292](http://purl.obolibrary.org/obo/MONDO_0011292) (dermatitis, atopic), [MONDO:0013294](http://purl.obolibrary.org/obo/MONDO_0013294) (atopic dermatitis 8), [MONDO:0011596](http://purl.obolibrary.org/obo/MONDO_0011596) (atopic dermatitis 2), [MONDO:0013295](http://purl.obolibrary.org/obo/MONDO_0013295) (atopic dermatitis 9), [MONDO:0007817](http://purl.obolibrary.org/obo/MONDO_0007817) (Ige responsiveness, atopic), [MONDO:0002138](http://purl.obolibrary.org/obo/MONDO_0002138) (allergic contact dermatitis of eyelid), [MONDO:0006616](http://purl.obolibrary.org/obo/MONDO_0006616) (toxicodendron dermatitis), [MONDO:0011608](http://purl.obolibrary.org/obo/MONDO_0011608) (atopic dermatitis 5), [MONDO:0006514](http://purl.obolibrary.org/obo/MONDO_0006514) (recalcitrant atopic dermatitis), [MONDO:0006525](http://purl.obolibrary.org/obo/MONDO_0006525) (allergic contact dermatitis), [MONDO:0006596](http://purl.obolibrary.org/obo/MONDO_0006596) (photoallergic dermatitis), [MONDO:0011609](http://purl.obolibrary.org/obo/MONDO_0011609) (atopic dermatitis 6), [MONDO:0001290](http://purl.obolibrary.org/obo/MONDO_0001290) (allergic cutaneous vasculitis), [MONDO:0011598](http://purl.obolibrary.org/obo/MONDO_0011598) (atopic dermatitis 4), [MONDO:0011597](http://purl.obolibrary.org/obo/MONDO_0011597) (atopic dermatitis 3), [MONDO:0013107](http://purl.obolibrary.org/obo/MONDO_0013107) (atopic dermatitis 7), 

**Mapped go classes:** [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:1901741](http://purl.obolibrary.org/obo/GO_1901741) (positive regulation of myoblast fusion), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0022008](http://purl.obolibrary.org/obo/GO_0022008) (neurogenesis), [GO:0001786](http://purl.obolibrary.org/obo/GO_0001786) (phosphatidylserine binding), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0070287](http://purl.obolibrary.org/obo/GO_0070287) (ferritin receptor activity), [GO:0003847](http://purl.obolibrary.org/obo/GO_0003847) (1-alkyl-2-acetylglycerophosphocholine esterase activity), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0002639](http://purl.obolibrary.org/obo/GO_0002639) (positive regulation of immunoglobulin production), [GO:0019767](http://purl.obolibrary.org/obo/GO_0019767) (IgE receptor activity), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:0046469](http://purl.obolibrary.org/obo/GO_0046469) (platelet activating factor metabolic process), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043113](http://purl.obolibrary.org/obo/GO_0043113) (receptor clustering), [GO:0043236](http://purl.obolibrary.org/obo/GO_0043236) (laminin binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0030414](http://purl.obolibrary.org/obo/GO_0030414) (peptidase inhibitor activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0035701](http://purl.obolibrary.org/obo/GO_0035701) (hematopoietic stem cell migration), [GO:0033005](http://purl.obolibrary.org/obo/GO_0033005) (positive regulation of mast cell activation), [GO:0019979](http://purl.obolibrary.org/obo/GO_0019979) (interleukin-4 binding), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:1902572](http://purl.obolibrary.org/obo/GO_1902572) (negative regulation of serine-type peptidase activity), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0008201](http://purl.obolibrary.org/obo/GO_0008201) (heparin binding), [GO:0045785](http://purl.obolibrary.org/obo/GO_0045785) (positive regulation of cell adhesion), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0001530](http://purl.obolibrary.org/obo/GO_0001530) (lipopolysaccharide binding), [GO:0042832](http://purl.obolibrary.org/obo/GO_0042832) (defense response to protozoan), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0019863](http://purl.obolibrary.org/obo/GO_0019863) (IgE binding), [GO:0030246](http://purl.obolibrary.org/obo/GO_0030246) (carbohydrate binding), [GO:0034441](http://purl.obolibrary.org/obo/GO_0034441) (plasma lipoprotein particle oxidation), [GO:0034440](http://purl.obolibrary.org/obo/GO_0034440) (lipid oxidation), [GO:0060097](http://purl.obolibrary.org/obo/GO_0060097) (cytoskeletal rearrangement involved in phagocytosis, engulfment), [GO:0048306](http://purl.obolibrary.org/obo/GO_0048306) (calcium-dependent protein binding), [GO:0043652](http://purl.obolibrary.org/obo/GO_0043652) (engulfment of apoptotic cell), [GO:0097241](http://purl.obolibrary.org/obo/GO_0097241) (hematopoietic stem cell migration to bone marrow), [GO:0004896](http://purl.obolibrary.org/obo/GO_0004896) (cytokine receptor activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0050900](http://purl.obolibrary.org/obo/GO_0050900) (leukocyte migration), [GO:0050901](http://purl.obolibrary.org/obo/GO_0050901) (leukocyte tethering or rolling), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0033623](http://purl.obolibrary.org/obo/GO_0033623) (regulation of integrin activation), [GO:0043306](http://purl.obolibrary.org/obo/GO_0043306) (positive regulation of mast cell degranulation), [GO:0007213](http://purl.obolibrary.org/obo/GO_0007213) (G-protein coupled acetylcholine receptor signaling pathway), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0097286](http://purl.obolibrary.org/obo/GO_0097286) (iron ion import), [GO:0043032](http://purl.obolibrary.org/obo/GO_0043032) (positive regulation of macrophage activation), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0097209](http://purl.obolibrary.org/obo/GO_0097209) (epidermal lamellar body), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0090026](http://purl.obolibrary.org/obo/GO_0090026) (positive regulation of monocyte chemotaxis), [GO:0033691](http://purl.obolibrary.org/obo/GO_0033691) (sialic acid binding), [GO:0043277](http://purl.obolibrary.org/obo/GO_0043277) (apoptotic cell clearance), [GO:0002691](http://purl.obolibrary.org/obo/GO_0002691) (regulation of cellular extravasation), [GO:0002687](http://purl.obolibrary.org/obo/GO_0002687) (positive regulation of leukocyte migration), [GO:0004867](http://purl.obolibrary.org/obo/GO_0004867) (serine-type endopeptidase inhibitor activity), [GO:0009913](http://purl.obolibrary.org/obo/GO_0009913) (epidermal cell differentiation), [GO:0016042](http://purl.obolibrary.org/obo/GO_0016042) (lipid catabolic process), [GO:0010466](http://purl.obolibrary.org/obo/GO_0010466) (negative regulation of peptidase activity), [GO:0035584](http://purl.obolibrary.org/obo/GO_0035584) (calcium-mediated signaling using intracellular calcium source), [GO:0034374](http://purl.obolibrary.org/obo/GO_0034374) (low-density lipoprotein particle remodeling), [GO:0007157](http://purl.obolibrary.org/obo/GO_0007157) (heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules), [GO:0090197](http://purl.obolibrary.org/obo/GO_0090197) (positive regulation of chemokine secretion), [GO:0045861](http://purl.obolibrary.org/obo/GO_0045861) (negative regulation of proteolysis), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0045626](http://purl.obolibrary.org/obo/GO_0045626) (negative regulation of T-helper 1 cell differentiation), [GO:0007159](http://purl.obolibrary.org/obo/GO_0007159) (leukocyte cell-cell adhesion), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0002532](http://purl.obolibrary.org/obo/GO_0002532) (production of molecular mediator involved in inflammatory response), [GO:0071354](http://purl.obolibrary.org/obo/GO_0071354) (cellular response to interleukin-6), [GO:0047499](http://purl.obolibrary.org/obo/GO_0047499) (calcium-independent phospholipase A2 activity), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0050776](http://purl.obolibrary.org/obo/GO_0050776) (regulation of immune response), [GO:0010572](http://purl.obolibrary.org/obo/GO_0010572) (positive regulation of platelet activation), [GO:0031092](http://purl.obolibrary.org/obo/GO_0031092) (platelet alpha granule membrane), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0042806](http://purl.obolibrary.org/obo/GO_0042806) (fucose binding), [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:1900004](http://purl.obolibrary.org/obo/GO_1900004) (negative regulation of serine-type endopeptidase activity), [GO:0005543](http://purl.obolibrary.org/obo/GO_0005543) (phospholipid binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0070492](http://purl.obolibrary.org/obo/GO_0070492) (oligosaccharide binding), [GO:0002787](http://purl.obolibrary.org/obo/GO_0002787) (negative regulation of antibacterial peptide production), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0005938](http://purl.obolibrary.org/obo/GO_0005938) (cell cortex), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030155](http://purl.obolibrary.org/obo/GO_0030155) (regulation of cell adhesion), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 53.99%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 51.28%
- [GO:0034362](http://purl.obolibrary.org/obo/GO_0034362) (low-density lipoprotein particle) 51.28%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.28%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 36.64%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 36.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 36.64%


